Oral immunotherapy using partially hydrolyzed formula for cow's milk protein allergy: A randomized, controlled trial

Background Partially hydrolyzed cow's milk protein-based formula (pHF) possesses low allergenicity. Here, we investigate the safety and efficacy of oral immunotherapy using pHF for children with cow's milk protein allergy (CMPA).